ZWJ Investment Counsel’s Regeneron Pharmaceuticals REGN Stock Holding History

ZWJ Investment Counsel’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-479	Closed	-$304K	–	249
2025 Q1	$304K	Hold	479	–	–	0.01%	182
2024 Q4	$341K	Buy	479 +1	+0.2%	+$839	0.01%	173
2024 Q3	$502K	Hold	478	–	–	0.02%	149
2024 Q2	$502K	Hold	478	–	–	0.02%	143
2024 Q1	$460K	Buy	+478	New	+$455K	0.02%	155
2020 Q2	–	Sell	-728	Closed	-$355K	–	184
2020 Q1	$355K	Hold	728	–	–	0.03%	157
2019 Q4	$273K	Buy	+728	New	+$245K	0.02%	193

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ZWJ Investment Counsel's REGN Position: Q2 2025 in Review

ZWJ Investment Counsel sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 479 shares — an estimated $304K sold.

ZWJ Investment Counsel first reported a position in REGN in Q4 2019 and held it in 7 quarters. The position peaked at $502K in Q3 2024. 1,203 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

ZWJ Investment Counsel reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
ZWJ Investment Counsel sold 479 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $304K.
ZWJ Investment Counsel first reported a position in Regeneron Pharmaceuticals in Q4 2019 and held it in 7 quarters.
ZWJ Investment Counsel's Regeneron Pharmaceuticals position peaked at $502K in Q3 2024.
1,203 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on ZWJ Investment Counsel's 13F filing for Q2 2025, filed 21 Jul 2025.